Kontafarma China Holdings Limited (HKG:1312)
Hong Kong · Delayed Price · Currency is HKD
0.0280
-0.0020 (-6.67%)
Apr 24, 2026, 3:59 PM HKT
Revenue by Segment
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 197.74M | 215.44M | 201.98M | 171.16M | 161.28M | | | | | |
| -8.21% | 6.66% | 18.00% | 6.12% | -0.90% | | | | | |
| 716.97M | 682.09M | 607.13M | 722.90M | 641.99M | | | | | |
Pharmaceutical Business Growth | 5.11% | 12.35% | -16.01% | 12.60% | -24.15% | | | | | |
| 914.71M | 897.52M | 809.11M | 894.06M | 803.27M | | | | | |
| 1.92% | 10.93% | -9.50% | 11.30% | -20.40% | | | | | |
Revenue by Geography
Financials in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | Dec '18 Dec 31, 2018 | Dec '17 Dec 31, 2017 | Dec '16 Dec 31, 2016 |
|---|
| 696.10M | 650.15M | 592.37M | 714.92M | 623.67M | | | | | |
| 7.07% | 9.75% | -17.14% | 14.63% | -11.23% | | | | | |
| 181.19M | 178.90M | 162.81M | 133.36M | 123.49M | | | | | |
| 1.28% | 9.89% | 22.08% | 7.99% | 12.35% | | | | | |
| 16.55M | 37.43M | 39.17M | 38.78M | 38.49M | | | | | |
| -55.80% | -4.44% | 1.01% | 0.75% | -28.37% | | | | | |
| 20.87M | 31.04M | 14.77M | 7.01M | 17.63M | | | | | |
| -32.76% | 110.23% | 110.72% | -60.25% | 22.44% | | | | | |
| 914.71M | 897.52M | 809.11M | 894.06M | 803.27M | | | | | |
| 1.92% | 10.93% | -9.50% | 11.30% | -20.40% | | | | | |
Source: S&P Global Market Intelligence.